Actively Recruiting
Novel Regimens in COVID-19 Treatment
Led by Tanta University · Updated on 2020-12-04
160
Participants Needed
2
Research Sites
551 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Nitazoxanide has been shown to have a clinical efficacy against severe acute respiratory syndrome coronavirus 2; ivermectin has also demonstrated a remarkable experimental efficacy with a potential to be used for Coronavirus disease 2019.
CONDITIONS
Official Title
Novel Regimens in COVID-19 Treatment
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with COVID-19 infection
You will not qualify if you...
- Allergy or contraindication to the drugs.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Tanta University, Assiut University
Tanta, Egypt, 35111
Actively Recruiting
2
Sherief Abd-Elsalam
Tanta, Egypt
Actively Recruiting
Research Team
S
Sherief Abd-Elsalam, ass. prof.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here